Norethindrone And Ethinyl Estradiol And Ferrous Fumarate
Product Images NDC 68180-897

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Norethindrone And Ethinyl Estradiol And Ferrous Fumarate (NDC 68180-897). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Norethindrone (F704dd21 68d1 4697 B07f 4e07a8a9c29c 01)

Chemical structure diagram of the active ingredient in Norethindrone and Ethinyl Estradiol and Ferrous Fumarate, showing molecular rings, hydroxyl group, and other functional groups typical of steroid hormones.*

FDA Label Image

Ethinyl Estradiol (F704dd21 68d1 4697 B07f 4e07a8a9c29c 02)

Chemical structure diagram of an active ingredient, showing a steroid backbone with hydroxyl and methyl groups, and an ethynyl substituent at the C17 position. The structure is consistent with a steroidal compound such as Ethinyl Estradiol.*

FDA Label Image

Figure 1 (F704dd21 68d1 4697 B07f 4e07a8a9c29c 03)

A bar chart titled 'Circulatory Disease Mortality Rates per 100,000 Women-Years by Age, Smoking Status and Oral Contraceptive Use.' The x-axis shows age groups (15-24, 25-34, 35-44, 45+), and the y-axis shows mortality rate from 0 to 250 deaths per 100,000 woman-years. Four categories are represented by different colored bars: Ever-Users (Nonsmokers), Ever-Users (Smokers), Controls (Nonsmokers), and Controls (Smokers), showing mortality rates varying by age and smoking status.*

FDA Label Image

Pill Pack (F704dd21 68d1 4697 B07f 4e07a8a9c29c 04)

Blister card for Norethindrone and Ethinyl Estradiol and Ferrous Fumarate tablets, 0.4 mg/35 mcg, from Lupin Pharmaceuticals, Inc. The card displays a 28-day supply with four weeks of pills arranged in rows by day (Sunday through Saturday). Weeks 1, 2, and 3 are labeled as active, and Week 4 as inactive. The card includes a barcode and instructions referencing the day labels for first use.*

FDA Label Image

Pill Pack (F704dd21 68d1 4697 B07f 4e07a8a9c29c 05)

Blister card for Norethindrone and Ethinyl Estradiol and Ferrous Fumarate tablets, showing a 28-day regimen divided into four rows labeled Week 1 (active), Week 2 (active), Week 3 (active), and Week 4 (inactive). Each row contains seven circular pills arranged by day of the week from Sunday to Saturday. The card includes Lupin Pharmaceuticals branding and dosage strength of 0.4 mg/35 mcg.*

FDA Label Image

Lupin Logo (F704dd21 68d1 4697 B07f 4e07a8a9c29c 06)

FDA Label Image

Norethindrone And Ethinyl Estradiol Tablets, Chewable And Ferrous Fumarate Tablets 0.4 mg/35 Mcg (F704dd21 68d1 4697 B07f 4e07a8a9c29c 07)

Packaging label for Norethindrone and Ethinyl Estradiol and Ferrous Fumarate chewable tablets 0.4 mg/35 mcg by Lupin Pharmaceuticals, Inc. The label indicates a 28-day regimen with 5 blister cards, each containing 28 tablets. The label has a pink background with Lupin branding and includes storage instructions and regulatory information.*

FDA Label Image

Blister Card (F704dd21 68d1 4697 B07f 4e07a8a9c29c 08)

Blister pack label for Norethindrone and Ethinyl Estradiol and Ferrous Fumarate tablets by Lupin Pharmaceuticals, Inc. The label shows a grid of 28 circular dose indicators arranged in four rows of seven, each marked with a plus symbol. Days of the week are listed in pink across the top (Sunday through Saturday), with a 'START' indicator on the upper left. The bottom right notes the tablet strength as 0.4 mg/35 mcg.*

FDA Label Image

Blister Card (F704dd21 68d1 4697 B07f 4e07a8a9c29c 09)

A printed calendar layout showing days of the week arranged in horizontal rows with sequences shifting across each row. Below the calendar, there is a boxed warning in pink text stating that the product, like all oral contraceptives, is intended to prevent pregnancy but does not protect against HIV infection (AIDS) or other sexually transmitted diseases.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.